Director of Partnership Development

12983, Saranac Lake
Mar 30, 2021
Required Education
Masters Degree/MBA
Position Type
Full time

The President’s office at Trudeau Institute has an immediate opening for a Director of Partnership Development to amplify the scale of business relationships and partnership revenues, that grow by leveraging the Institute’s robust and proven biomedical laboratory capabilities in fighting infectious diseases.

The Director of Partnership Development identifies, plans and leads the pursuit of business partnership opportunities of significant scale, with focus on biotech, pharma and entrepreneurial clients with pipeline needs for preclinical research services in the infectious diseases and/or biopreparedness sector.  The Director is responsible for sourcing high-value leads, and, working with others in management, the Director will spearhead high-impact business development initiatives, including innovation in strategic partnering and joint ventures.  The Institute’s scientific teams have in recent years established a robust track record of program services revenue, performing high-caliber preclinical studies on candidate medicines and vaccines against the novel Coronavirus and more, and this leadership role is the opportunity to take the pipeline and revenue up to the next level.

OBJECTIVES AND RESPONSIBILITIES • Develop initiatives needed to attract partners and partnership revenue, bring qualified leads as top prospects to the internal Trudeau leadership team, and then in concert pursue skillfully to close research services and partnership contracts in these projects • Establish and build relationships with appropriate executives at qualified prospects, including pharma/biotech, disease-focused consortia, and entrepreneurial life sciences leaders, to cultivate and optimize significant new business opportunities • Identify and cultivate opportunities for entrepreneurial or consortium-based research strategic alliances • Develop and optimize financial terms in the larger contract-based business relationships • Contribute to infrastructure and investment analysis based on potential for revenue generation • Provide project management (business side) and support the development of the productive financial framework as defined by each alliance initiative

CAREER EXPERIENCE AND SPECIFIC SKILLS • Demonstrated ability to develop and close a multi-year research agreement • Excellent presentation skills - ability to prepare, edit and deliver excellent verbal and written communications and client presentations, both biomedical R&D and partnership-related • Skilled liaison with internal science team leaders, to understand the strengths of Trudeau's specialized research capability, to develop an excellent grasp of the attractive dimensions relevant for partners in our sector, then to marry these with the needs of specific prospective partners • Experience building relationships at the VP level in pharma, biotech, and life science enterprises • An impressive network of relevant contacts in pharma and research organizations • Organizational savvy, including the ability to identify and align stakeholders within the prospects with disparate needs and agendas • Engaging, empathetic and dynamic personality; ability to understand the problems of others and delight in finding solutions

Background on Trudeau Institute Trudeau Institute is a mission-directed non-profit research institute with a long history of infectious disease and immunology research, and in recent years has been advancing a new “Trudeau 3.0” era that specifically and successfully targets translational science capabilities of high relevance to partners in our network.  Our branded TICRO Bioservices operational team has been the hub driving a large proportion of our program services revenue to date.  Repeat business has been excellent. The Institute is engaged in seeking potential major partnerships for long-term coordinated research services and innovative collaborations to expand the scale and scope of external revenue.  Notably the Institute features a superb biosafety BSL-3 lab suite ideal for preclinical research on challenging pathogens from the ancient TB microbe to the novel Coronavirus. The Institute deploys our specialized BSL-2 and BSL-3 laboratory animal facility and technical staff into high-impact studies to accelerate new medicines and vaccines to protect our health against global-scale pathogens and emerging threats, from the pursuit of the universal influenza vaccine, to new defenses against antibiotic-resistant microbes, strengthening immunity in the elderly, and more.   The President of Trudeau Institute, Dr. Atsuo Kuki, is a former drug discovery technology executive in biotech and Pfizer Global R&D.  This perspective shapes our leadership team’s focus on high-value translational science, to bridge and to mutually serve the research institute’s and biopharma industry’s needs. Our priorities are to amplify our currently focused network of select biotech, pharma, and government partners, by expanding in innovative ways to new partners and clients who will serve as the cornerstone of our expanded program services revenue.